Brookings: mHealth Offers Solutions To Chinese Health Problems
This article was originally published in The Gray Sheet
Executive Summary
A Brookings Institution report makes the case for mobile Health as a partial solution to problems with health care delivery in China.
You may also be interested in...
Chinese Leadership Transitions, But Health Care Reforms Expected To Move Forward As Planned
“The Gray Sheet” interviewed four China experts on the occasion of the country’s leadership transition to gauge the impact of the change on ongoing health care reforms and device purchasing.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.